Perspective Therapeutics Inc (CATX) Stock: Surpassing Expectations in the Market?
BofA Securities has recently reduced Perspective Therapeutics Inc (CATX) stock to Neutral rating, as announced on November 25, 2024, according to Finviz. Earlier, on October 24, 2024, UBS had initiated the stock to Buy, setting a price target of $20. Wedbush also initiated Outperform rating with a price target of $25. Additionally, Truist initiated Buy […]
Perspective Therapeutics Inc (CATX) Stock: Understanding Its Underlying Value
BofA Securities has recently reduced Perspective Therapeutics Inc (CATX) stock to Neutral rating, as announced on November 25, 2024, according to Finviz. Earlier, on October 24, 2024, UBS had initiated the stock to Buy, setting a price target of $20. Wedbush also initiated Outperform rating with a price target of $25. Additionally, Truist initiated Buy […]
Perspective Therapeutics Inc (CATX) Stock: Understanding Its Underlying Value
BofA Securities has recently reduced Perspective Therapeutics Inc (CATX) stock to Neutral rating, as announced on November 25, 2024, according to Finviz. Earlier, on October 24, 2024, UBS had initiated the stock to Buy, setting a price target of $20. Wedbush also initiated Outperform rating with a price target of $25. Additionally, Truist initiated Buy […]
How Does Perspective Therapeutics Inc (CATX) Stack Up Against Its Industry Peers?
BofA Securities has recently reduced Perspective Therapeutics Inc (CATX) stock to Neutral rating, as announced on November 25, 2024, according to Finviz. Earlier, on October 24, 2024, UBS had initiated the stock to Buy, setting a price target of $20. Wedbush also initiated Outperform rating with a price target of $25. Additionally, Truist initiated Buy […]
Perspective Therapeutics Inc (CATX) Stock: Analyzing Its Quiet Power
BofA Securities has recently reduced Perspective Therapeutics Inc (CATX) stock to Neutral rating, as announced on November 25, 2024, according to Finviz. Earlier, on October 24, 2024, UBS had initiated the stock to Buy, setting a price target of $20. Wedbush also initiated Outperform rating with a price target of $25. Additionally, Truist initiated Buy […]
The Perspective Therapeutics Inc Enigma: What’s Causing the Wild Swings in CATX Stock?
UBS has recently initiated Perspective Therapeutics Inc (CATX) stock to Buy rating, as announced on October 24, 2024, according to Finviz. Earlier, on October 1, 2024, Wedbush had initiated the stock to Outperform, setting a price target of $25. Truist also initiated Buy rating with a price target of $21. Additionally, BofA Securities initiated Buy […]
What’s Behind the -51.38% Drop in Perspective Therapeutics Inc (CATX) Stock? Find Out Now!
UBS has recently initiated Perspective Therapeutics Inc (CATX) stock to Buy rating, as announced on October 24, 2024, according to Finviz. Earlier, on October 1, 2024, Wedbush had initiated the stock to Outperform, setting a price target of $25. Truist also initiated Buy rating with a price target of $21. Additionally, BofA Securities initiated Buy […]
Perspective Therapeutics Inc (CATX) Stock: More Robust Than the Numbers Suggest?
UBS has recently initiated Perspective Therapeutics Inc (CATX) stock to Buy rating, as announced on October 24, 2024, according to Finviz. Earlier, on October 1, 2024, Wedbush had initiated the stock to Outperform, setting a price target of $25. Truist also initiated Buy rating with a price target of $21. Additionally, BofA Securities initiated Buy […]
Wedbush Issues Outperform Rating for Perspective Therapeutics Inc (CATX) Stock
Wedbush has recently initiated Perspective Therapeutics Inc (CATX) stock to Outperform rating, as announced on October 1, 2024, according to Finviz. Earlier, on September 25, 2024, Truist had initiated the stock to Buy, setting a price target of $21. BofA Securities also initiated Buy rating with a price target of $24. Analyst ratings are significant […]
Perspective Therapeutics Inc (CATX) Stock Settles at $12.66: What’s Contributing to This Price Point?
Wedbush has recently initiated Perspective Therapeutics Inc (CATX) stock to Outperform rating, as announced on October 1, 2024, according to Finviz. Earlier, on September 25, 2024, Truist had initiated the stock to Buy, setting a price target of $21. BofA Securities also initiated Buy rating with a price target of $24. Analyst ratings are significant […]
